Clinical trial Recruiting at 1 site Interventional Ages 50 to 75

Gamified robotic rehabilitation for Parkinson's disease patients

Official title: A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease

Run by Adi Negev-Nahalat Eran · NCT06730074 · Data updated 2026-11-12

This study is testing a new robotic system that uses music and games to help people with Parkinson's disease improve their movement and thinking skills.

More Parkinson Disease, Idiopathic trials

Quick facts

Study typeInterventional
Ages50 Years to 75 Years
SexAll
Enrollment15 (estimated)
SponsorAdi Negev-Nahalat Eran
Academic / other
Locations1 site (Ofakim, South)
StatusRecruiting
StartedDecember 12, 2024
Main results expectedMarch 2025
Study endsAugust 2025
Registry record updatedDecember 17, 2024
Trial IDNCT06730074 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Hebrew-speaking men and women aged 50-75 with idiopathic Parkinson's disease and Hoehn and Yahr stage 3 or below.

Probably not a fit

Patients with Parkinson's plus syndromes or those with unrelated neurological symptoms may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate a novel robotic system designed for motor-cognitive rehabilitation in individuals with Parkinson's disease. Participants will engage in a series of sessions using the robotic platform, which incorporates music and gamification to enhance the rehabilitation experience. The study will assess both subjective user experiences and objective measures of motor and cognitive function before and after the intervention. A total of 15 patients aged 50-75 will participate, with assessments conducted by trained therapists to ensure accurate data collection.

Why it matters

Potential benefit: If successful, this innovative approach could significantly improve motor and cognitive symptoms in patients with Parkinson's disease.

How similar studies have gone: This approach is novel and has not been extensively tested in previous studies, making it a potentially groundbreaking intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signing the informed consent form
* Men and women in ages 50-75
* Hebrew speakers
* Have Idiopathic Parkinson's disease
* Hoehn and Yahr 3 and below
* Moca test 23 and above

Exclusion Criteria:

* Patients with Parkinson's plus syndromes
* PD patients who suffer from unrelated neurological symptoms.
* Orthopedic problems of the upper limb
* Recent surgery conducted on the upper limb
* Uncorrected vision problems
* Uncorrected severe hearing loss

Where it's running

  • Adi Negev
    Ofakim, South, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.